R&D JP Morgan 2024 – Frank Gleeson In this brief dispatch from JP Morgan, Editor in Chief Jonah Comstock grabs a few minutes with Frank Gleeson, CEO of Satellos Bioscience.
News In shock move, EU panel rejects Alzheimer's drug Leqembi The EMA's human medicines committee has recommended against approval of Eisai and Biogen's Alzheimer's disease therapy Leqembi, after regulators in the US, China and Japan gave a green ligh
Sales & Marketing Sponsored How doctors are interacting with content in 10 data trends It will come as no surprise to anyone in the healthcare space that doctors today are under an inordinate amount of pressure.
